UBS O'Connor’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $888K | Buy |
307,198
+127,171
| +71% | +$368K | 0.05% | 218 |
|
|
2025
Q1 | $387K | Sell |
180,027
-8,516
| -5% | -$18.3K | 0.01% | 210 |
|
|
2024
Q4 | $730K | Sell |
188,543
-14,240
| -7% | -$55.1K | 0.02% | 248 |
|
|
2024
Q3 | $1.33M | Sell |
202,783
-5,000
| -2% | -$32.8K | 0.03% | 240 |
|
|
2024
Q2 | $1.51M | Buy |
207,783
+5,000
| +2% | +$36.3K | 0.04% | 232 |
|
|
2024
Q1 | $1.54M | Sell |
202,783
-117,118
| -37% | -$889K | 0.04% | 226 |
|
|
2023
Q4 | $1.46M | Sell |
319,901
-58,604
| -15% | -$267K | 0.05% | 221 |
|
|
2023
Q3 | $1.5M | Buy |
378,505
+15,000
| +4% | +$59.3K | 0.03% | 284 |
|
|
2023
Q2 | $1.14M | Buy |
363,505
+151,011
| +71% | +$473K | 0.02% | 366 |
|
|
2023
Q1 | $963K | Buy |
+212,494
| New | +$963K | 0.02% | 404 |
|
|
2015
Q3 | – | Sell |
-6,683
| Closed | -$2.78M | – | 592 |
|
|
2015
Q2 | $2.78M | Buy |
6,683
+3,350
| +101% | +$1.39M | 0.05% | 305 |
|
|
2015
Q1 | $1.58M | Buy |
+3,333
| New | +$1.58M | 0.03% | 326 |
|